Onderneming Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES
Aandelen
0IVI
DK0060048148
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- DKK | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 01-03-16 |
Chief Tech/Sci/R&D Officer | - | 13-09-17 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 01-03-16 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 01-04-16 |
Rita L. Mannella
HRO | Human Resources Officer | - | 01-01-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 739 741 590 | 173 932 405 ( 9,998 %) | 0 | 9,998 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,29% | 80,5 mld. | |
+15,08% | 9,15 mld. | |
-18,33% | 4,9 mld. | |
+43,39% | 4,49 mld. | |
+13,95% | 4,44 mld. | |
+10,89% | 2,19 mld. | |
-28,40% | 2,13 mld. | |
+15,93% | 2,1 mld. | |
-43,17% | 1,78 mld. |
- Beurs
- Aandelen
- Koers VELO
- Koers 0IVI
- Onderneming Veloxis Pharmaceuticals A/S